Viewing Study NCT04046133


Ignite Creation Date: 2025-12-25 @ 3:04 AM
Ignite Modification Date: 2025-12-26 @ 1:43 AM
Study NCT ID: NCT04046133
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-05
First Post: 2018-01-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase 1b/II Trial of Pembrolizumab Plus IMRT in Stage III/IV Carcinoma of Anus
Sponsor: Cardiff University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module